Amber Therapeutics

Series-A
amber-tx.com Biotech & Healthcare London, United Kingdom Founded 2022 11-50
Total Funding $100M
Latest Round Undisclosed Series-A
Last Announced Jul 24, 2026
Investors 8 Backers
Decision Makers 3 Verified

About Amber Therapeutics

Amber Therapeutics develops an adaptive neuromodulation therapy for women with mixed urinary incontinence. Its fully implantable Picostim System targets the pudendal nerve to stimulate and sense physiological responses. The therapy is configurable to individual needs and adapts dynamically.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters London, United Kingdom
Year Founded 2022
Team Size 11-50
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website amber-tx.com
Domain Registered Date Dec 21, 2020

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Series-A announced

    fundraisingfox.com

  2. Capital Raise

    Raised $100,000,000 · Series-A

    fundraisingfox.com

  3. Milestone

    Company founded

    London, United Kingdom

  4. Milestone

    Website domain registered

    amber-tx.com

Investors & Backers

8
8VC
F-Prime Capital
Future Fifty
Innovate UK
Intuitive Ventures
Lightstone Ventures
NEA
Oxford Science Enterprises

Funding History

2 Rounds
Series-A · Jul 24, 2026
Series-A · Jun 10, 2024

Founders & Leadership

2

Aidan Crawley

Co-founder & CEO

Work email & phone locked Unlock →

Tim Denison

Co-founder & Chief Engineer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts